drugset / Trial / NCT07856719

A Ph2, Colchicine For Inflammatory Carotid Injury And Disease Evolution After Radiotherapy

NCT07856719 ↗

Phase 2 Not yet recruiting 250 enrolled M.D. Anderson Cancer Center
NaSingle-groupOpen-labelSupportive care

Summary

The goal of this clinical research study is to find out if low-dose colchicine (an anti-inflammatory drug) lowers the rate of radiation-related side effects to the carotid artery in patients who have completed radiation therapy for head and neck cancer.

Timeline

Start
2027-03-01
Primary completion
2032-07-01
Completion
2034-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Colchicine Small molecule 0.6 mg Oral

Indications